Validation of nigrostriatal positron emission tomography measures: critical limits.
about
The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimagingMolecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseNeuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model.Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism.Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography.Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's diseaseValidation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.Central pharmacokinetics of levodopa: Lessons from imaging studies.Neuroimaging biomarkers for Parkinson disease: facts and fantasy.In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.Radiosynthesis and in vivo evaluation of a novel σ1 selective PET ligand.Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques
P2860
Q26865047-8CDEA7AD-1584-4A14-B220-5B764F3AF02CQ31158920-E3A6A6B4-67E7-48BC-929E-0F58EA4F9C92Q33922530-019AF6C1-9345-42E6-A6CB-A7DF8B3D8E14Q34195302-F3BB3D1E-56F7-4D17-947E-9B50BF44777EQ35564787-F0E82722-DF31-40EE-9ABE-0AE6BBCC7272Q35681047-F8CDCC1F-0348-4CB1-A7A1-76431CA7214CQ35752092-8217374F-01A3-42E9-8F36-992DBDB97BBFQ36523068-C1FF9047-94B0-49E5-8A7A-2D5200134890Q36641307-5B75D550-7CFA-40D0-852A-062B176634C7Q37238890-CEF50E0B-60BB-4775-936C-94C28C8CF574Q38255967-9B676A73-83FF-401C-8E32-5E56EBD1C47EQ38264397-F0AB4CA9-6656-488C-9FC5-7A3564D14585Q39758264-7BC05653-0548-4B62-B388-87DDEA4141BDQ42362025-F9BA6CBA-0B6A-4283-BFD6-879FDD30DB38Q43097520-3FAC3DC8-BA9C-48E8-876F-2DE80FBAB150Q43526336-9F572BAD-4061-4816-AE68-3A3FFFE29924Q47651254-EDFB9456-B301-4E23-B465-BABB0996EAC0Q58763751-41C67DE8-BE22-4CEF-AAC7-8E5C69CB3585
P2860
Validation of nigrostriatal positron emission tomography measures: critical limits.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Validation of nigrostriatal positron emission tomography measures: critical limits.
@ast
Validation of nigrostriatal positron emission tomography measures: critical limits.
@en
type
label
Validation of nigrostriatal positron emission tomography measures: critical limits.
@ast
Validation of nigrostriatal positron emission tomography measures: critical limits.
@en
prefLabel
Validation of nigrostriatal positron emission tomography measures: critical limits.
@ast
Validation of nigrostriatal positron emission tomography measures: critical limits.
@en
P2093
P2860
P356
P1433
P1476
Validation of nigrostriatal positron emission tomography measures: critical limits.
@en
P2093
Christopher A Brown
Hubert P Flores
LinLin Tian
Morvarid Karimi
Stephen M Moerlein
Susan K Loftin
P2860
P304
P356
10.1002/ANA.23798
P577
2013-02-19T00:00:00Z